Tight and early HbA1c control in patients with type 2 diabetes mellitus in Spain : quantifying the social value
Merino, María (Department of Health Outcomes Research)
Maravilla-Herrera, Paulina (Department of Health Outcomes Research)
Artola, Sara (Red de Grupos de Estudio en Atención Primaria de Salud (redGDPS) Foundation)
Escalada, Javier (Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición)
Pérez Pérez, Antonio (Institut de Recerca Sant Pau)
Hidalgo, Álvaro (Fundación Weber)
Remón, Juantxo (Federación Española de Diabetes)
Trillo-Mata, José L. (Conselleria de Sanitat Universal i Salut Pública. Comunitat Valenciana)
Vallès-Callol, Joan A. (Institut Català de la Salut)
Universitat Autònoma de Barcelona. Departament de Medicina

Data:	2025
Resum:	Introduction: The aim of this study was to estimate the social value of a tight and early control of patients with type 2 diabetes during the 5 years after diagnosis in Spain, compared to higher hemoglobin A1c (HbA) goals. Methods: An economic model based on the scientific literature was used to estimate the 5-year social value of maintaining tight and early type 2 diabetes control, i. e. , keeping HbA levels <6. 5%, during the 5 years after diagnosis in Spain, compared to non-tight control. Areas of analysis included healthcare resource utilization, the presence of complications, quality of life, and mortality. The outcomes corresponding to these two types of control (tight vs. non-tight) were multiplied by their unit cost or financial proxy to obtain the economic impact associated with each type of control. Social value was estimated as the reduction in the economic impact of a non-tight control when tight control is implemented and maintained. The results are expressed in euros for the year 2021. Results: The economic impact of tight control during the first 5 years after type 2 diabetes diagnosis was estimated to be €1,010 million in Spain (€13,473 per patient), which is lower than the impact of non-tight control, which was estimated to be €1,127 million (€16,122 per patient) during the same period. Conclusion: Maintaining tight and early control of type 2 diabetes during the first 5 years after diagnosis could generate a positive social value of €2,649 per patient over that period, in terms of better health outcomes, increased quality of life, and decreased premature deaths.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Complications ; Glycemic control ; Hospitalizations ; Monitoring ; Mortality ; Quality of life ; Socioeconomic impact ; Type 2 diabetes
Publicat a:	Frontiers in Public Health, Vol. 13 (2025) , art. 1511108, ISSN 2296-2565

DOI: 10.3389/fpubh.2025.1511108
PMID: 40717941

9 p, 857.1 KB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut de Recerca Sant Pau
Articles > Articles de recerca
Articles > Articles publicats